GEN-DILTIAZEM SR 60MG 60 MG — DIN 02231743
DILTIAZEM HYDROCHLORIDE : 60 MG · GENPHARM ULC · CAPSULE (SUSTAINED-RELEASE) · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is GEN-DILTIAZEM SR 60MG?
GEN-DILTIAZEM SR 60MG 60 MG contains DILTIAZEM HYDROCHLORIDE : 60 MG. It is listed in the Health Canada Drug Product Database under DIN 02231743, held by GENPHARM ULC, supplied as CAPSULE (SUSTAINED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 05-Aug-2009. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is GEN-DILTIAZEM SR 60MG used for?
Treatment of mild to moderate infections: Upper/lower respiratory tract, skin/skin structure, and sexually transmitted diseases (urethritis/cervicitis) caused by susceptible organisms.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Diltiazem cost around the world?
Diltiazem is listed on 3 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Austria publishes a KVP (Kassenverkaufspreis); Czechia publishes a max producer price (ex-factory); Luxembourg publishes a reimbursement. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Luxembourg | reimbursement | 10 | 10 | EUR███.██ |
| Austria | KVP (Kassenverkaufspreis) | 4 | 7 | EUR███.██ |
| Czechia | max producer price (ex-factory) | 1 | 2 | CZK███.██ |
19 pack listings across 15 brand entries and 3 price bases, refreshed 05 Sep 2026. Ranges span every Diltiazem pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Diltiazem in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
31 holders have a Canadian DIN containing Diltiazem, across 175 DINs, of which 75 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 20 | 13 | ACT DILTIAZEM CD, DILTIAZEM HYDROCHLORIDE INJECTION, TEVA-DILTIAZEM, TEVA-DILTIAZEM CD, TEVA-DILTIAZEM T, +1 more | Sourceable in Canada |
| BAUSCH HEALTH, CANADA INC. | 19 | 10 | CARDIZEM CD, TEVA-DILTIAZEM HCL ER, TIAZAC, TIAZAC XC | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 9 | 9 | JAMP DILTIAZEM CD, JAMP DILTIAZEM T | Sourceable in Canada |
| MANTRA PHARMA INC | 9 | 9 | M-DILTIAZEM CD, M-DILTIAZEM T | Sourceable in Canada |
| SANIS HEALTH INC | 9 | 9 | DILTIAZEM CD, DILTIAZEM T | Sourceable in Canada |
| MARCAN PHARMACEUTICALS INC | 8 | 8 | MAR-DILTIAZEM CD, MAR-DILTIAZEM T | Sourceable in Canada |
| PRO DOC LIMITEE | 15 | 4 | DILTIAZEM TZ, DILTIAZEM-30 TAB 30MG, DILTIAZEM-60 TAB 60MG, DILTIAZEM-CD, PRO-DILTIAZEM CD | Sourceable in Canada |
| APOTEX INC | 13 | 4 | APO-DILTIAZ CD, APO-DILTIAZ INJECTABLE, APO-DILTIAZ SR, APO-DILTIAZ TZ | Sourceable in Canada |
| SIVEM PHARMACEUTICALS ULC | 4 | 4 | DILTIAZEM CD | Sourceable in Canada |
| AA PHARMA INC | 2 | 2 | AA-DILTIAZ | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 10 | 1 | DILTIAZEM HYDROCHLORIDE INJECTION, SANDOZ DILTIAZEM CD, SANDOZ DILTIAZEM T | Sourceable in Canada |
| MARCAN PHARMACEUTICALS INC 2 Gurdwara Rd., Suite 400 Ottawa Ontario Canada K2E 1A2 | 1 | 1 | MAR-DILTIAZEM T | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 60 MG |
|---|---|
| Dosage form | CAPSULE (SUSTAINED-RELEASE) |
| Route | ORAL |
| Pack configuration (monograph) | Available in bottles of 30 and 100 tablets, and blister packs of 6 tablets. |
| Storage | Store at controlled room temperature (15°C to 30°C). |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Diltiazem |
|---|---|
| ATC code | C08DB01 |
| AHFS class | 24:28.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02231743 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2231743 |
| Brand name | GEN-DILTIAZEM SR 60MG |
| Generic / active ingredient | DILTIAZEM HYDROCHLORIDE : 60 MG |
| Market authorization holder | GENPHARM ULC |
| Health Canada schedule | Prescription |
| ATC code | C08DB01 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C08DB |
| Current status | CANCELLED POST MARKET |
| Status date | 05-Aug-2009 |
| Original market date | 1997-07-18 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults: 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5. For certain infections, 500 mg once daily for 3 days. May be taken with or without food.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to azithromycin, erythromycin, any macrolide or ketolide antibacterial agent, or any ingredient in the formulation. History of cholestatic jaundice/hepatic dysfunction.
Warnings and precautions
Serious allergic reactions (angioedema, anaphylaxis, Stevens-Johnson syndrome). Hepatotoxicity. QT interval prolongation and cardiovascular risks. Clostridium difficile-associated diarrhea.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
75 of 175 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AA-DILTIAZ | 30 MG | TABLET | AA PHARMA INC | MARKETED | 00771376 |
| AA-DILTIAZ | 60 MG | TABLET | AA PHARMA INC | MARKETED | 00771384 |
| APO-DILTIAZ CD | 120 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | 02230997 |
| APO-DILTIAZ CD | 240 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | 02230999 |
| APO-DILTIAZ CD | 180 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | 02230998 |
| APO-DILTIAZ CD | 300 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | 02229526 |
| DILTIAZEM CD | 180 MG | CAPSULE (CONTROLLED-DELIVERY) | SANIS HEALTH INC | MARKETED | 02400448 |
| DILTIAZEM CD | 120 MG | CAPSULE (CONTROLLED-DELIVERY) | SANIS HEALTH INC | MARKETED | 02400421 |
| DILTIAZEM CD | 240 MG | CAPSULE (CONTROLLED-DELIVERY) | SANIS HEALTH INC | MARKETED | 02400456 |
| DILTIAZEM CD | 300 MG | CAPSULE (CONTROLLED-DELIVERY) | SANIS HEALTH INC | MARKETED | 02400464 |
2 · Same class — other molecules in ATC C08DB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Diltiazem | AA-DILTIAZ · ACT DILTIAZEM CD · ALTI-DILTIAZEM TAB 30MG · ALTI-DILTIAZEM TAB 60MG · +61 more | 175 | 75 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC C08D
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| C08DA | Verapamil | 53 | 5 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is GEN-DILTIAZEM SR 60MG called?
The same molecule, Diltiazem, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| DIACORDIN RETARD | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Diltiazem called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Diltiazem, published to help those searches reach this page.
| Language | Diltiazem |
|---|---|
| Chinese (Simplified) 简体中文 | 地尔硫卓 |
| Spanish Español | diltiazem |
| French Français | diltiazem |
| Portuguese Português | diltiazem |
| German Deutsch | Diltiazem |
| Hindi हिन्दी | डिल्टियाज़ेम |
| Turkish Türkçe | diltiazem |
| Vietnamese Tiếng Việt | diltiazem |
| Indonesian Bahasa Indonesia | diltiazem |
| Polish Polski | diltiazem |
| Italian Italiano | diltiazem |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.